Because a high rate of laryngeal preservation was achieved without compromising disease-specific survival, our treatment approach based on FAR therapy may be promising for the treatment of patients with T2N0 glottic carcinoma.
No takes yet. Share an insight, caveat, or question.
Kumamoto et al. (2002) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: